TrialPloS one2013

The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study.

Justin Stebbing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.